中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2011年
9期
42-44
,共3页
血栓通注射液%癌症相关静脉血栓
血栓通註射液%癌癥相關靜脈血栓
혈전통주사액%암증상관정맥혈전
Xueshuantong injection%Cancer-related venous blood clots
目的 观察血栓通注射液对癌症相关静脉血栓的防治作用及对癌症患者生存质量的影响.方法 观察组230例患者在住院放化疗治疗的同时加用血栓通注射液静脉滴注,对照组230例仅做放、化疗,治疗结束后对两组患者静脉血栓的发生率及生活质量(Karnof - sky评分)进行评价.结果 观察组血栓发生率为1.15%,对照组血栓发生率为16.96%.Karnof-sky评分:观察组改善118例,稳定82例;对照组改善72例,稳定47例,两组比较差异有统计学意义(P<0.05).结论 血栓通注射液对癌症相关静脉血栓有预防作用,对该类癌症患者的生存质量有明显提高作用.
目的 觀察血栓通註射液對癌癥相關靜脈血栓的防治作用及對癌癥患者生存質量的影響.方法 觀察組230例患者在住院放化療治療的同時加用血栓通註射液靜脈滴註,對照組230例僅做放、化療,治療結束後對兩組患者靜脈血栓的髮生率及生活質量(Karnof - sky評分)進行評價.結果 觀察組血栓髮生率為1.15%,對照組血栓髮生率為16.96%.Karnof-sky評分:觀察組改善118例,穩定82例;對照組改善72例,穩定47例,兩組比較差異有統計學意義(P<0.05).結論 血栓通註射液對癌癥相關靜脈血栓有預防作用,對該類癌癥患者的生存質量有明顯提高作用.
목적 관찰혈전통주사액대암증상관정맥혈전적방치작용급대암증환자생존질량적영향.방법 관찰조230례환자재주원방화료치료적동시가용혈전통주사액정맥적주,대조조230례부주방、화료,치료결속후대량조환자정맥혈전적발생솔급생활질량(Karnof - sky평분)진행평개.결과 관찰조혈전발생솔위1.15%,대조조혈전발생솔위16.96%.Karnof-sky평분:관찰조개선118례,은정82례;대조조개선72례,은정47례,량조비교차이유통계학의의(P<0.05).결론 혈전통주사액대암증상관정맥혈전유예방작용,대해유암증환자적생존질량유명현제고작용.
Objective To observe the preventive and therapeutic effect of xueshuantong injection on cancer-related venous blood clots and the influence on the quality of cancer patients'life. Methods Four hundred and sixty cancer patients were randomly divided into two groups, 230 cases in the treatment group and 230 cases in the control group. Both groups received radiotherapy and chemotherapy, and to the treatment group, intravenous dripping of xueshuantong injection was added.The incidence rate of venous blood clots was observed and the quality of life was evaluated by Karnof-sky performance score(KPS).Results The incidence rate of venous blood clots was 1.15% in the treatment group,which was lower than that in the control group(16.96%),P<0.05.Cases experienced symptom inprovement were found more in the treatment group(118/230,51.30%)than in the control group(72/230,31.30%),P<0.05. Patients in stable condition were more in the treatment group(82/230,35.65%)than in the control group(47/230,20.43%),P<0.05. Conclusions Xueshuantong injection shows definite effect in preventing cancer-related venous blood clots and improving the quality of cancer patients'life.